Popular Articles From: Energy stocks are top decliners in S&P 500 to EVINE Live Inc. Names Wade Gerten Vice President of Digital


2014/11/4
By Claudia Assis, MarketWatch SAN FRANCISCO (MarketWatch) -- Energy stocks led a Tuesday decline in U.S. stocks, dragged down by multiyear lows in oil futures prices precipitated by news that Saudi Arabia, the world's No.
Sign-up for Energy stocks are top decliners in S&P 500 investment picks
2015/1/9
By Claudia Assis, MarketWatch SAN FRANCISCO (MarketWatch) -- Wall Street is bracing for a 20% decline in energy companies' earnings in the fourth quarter -- and that's the good news.
Sign-up for Energy stocks brace for many quarters of earnings pressure investment picks
By Tomi Kilgore, MarketWatch Crude oil futures turn higher, but shale-oil producers still getting pounded Energy stocks were in broad decline Monday, as a sharp turn higher in crude oil prices failed to fuel any investor optimism in the recently beaten-down sector.
Sign-up for Energy stocks pummeled again, despite crude's bounce investment picks
By Claudia Assis, MarketWatch Credit Suisse cuts oil-field services companies; Citi says buy SAN FRANCISCO (MarketWatch) -- Energy stocks led the S&P 500 Index on Tuesday, rebounding from recent losses that followed sharp declines for crude futures prices.
Sign-up for Energy stocks rebound to lead S&P 500 investment picks
BOSTON and VANCOUVER, British Columbia, Dec.
Sign-up for EnerNOC Acquires Leading Customer Engagement Software Provider for Utilities investment picks
Engility Holdings, Inc. (NYSE: EGL) today announced its receipt of notice from the Federal Trade Commission of the early termination of the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”) with respect to Engility’s proposed acquisition of TASC.
Sign-up for Engility Announces Early Termination of Hart-Scott-Rodino Waiting Period for Proposed Acquisition of TASC investment picks
2014/12/1
Industry-leading indoor green adds new experience to the ultimate home game room BRISTOL, Wis.
Sign-up for Enjoy Perfect Putting Conditions Year-Round and Improve Your Golf Game with The ONLY Green by Brunswick investment picks
First New Medical Device Approved for Obesity in Over a Decade Novel Neuroscience-Based Technology Enables Safe, Durable Weight Loss Company to Host Conference Call Today at 12:00 PM ET ST.
Sign-up for EnteroMedics Announces FDA Approval of VBLOC® Vagal Blocking Therapy for the Treatment of Obesity investment picks
2014/11/12
Enterprise Products Partners L.P. (NYSE:EPD, “Enterprise”) and Oiltanking Partners, L.P. (NYSE:OILT, “Oiltanking Partners”) announced today that Enterprise and Oiltanking Partners have entered into a merger agreement.
Sign-up for Enterprise Products and Oiltanking Partners Announce Merger Agreement investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G024905-001&sourceType=1 SOUTH SAN FRANCISCO, CA--(Marketwired - October 29, 2014) - A global leader and innovator of multi-screen video software worldwide, Envivio (NASDAQ: ENVI) today announced it will showcase its latest advancements in multi-screen, 4K and virtualized video processing, delivery and personalization for pay TV operators in the Middle East and North Africa (MENA) regions at TV Connect MENA 2014, Nov.
Sign-up for Envivio to Feature Multi-Screen, 4K and Cloud-Based Video at TV Connect MENA 2014 investment picks
MIGDAL HA'EMEQ, Israel, Nov.
Sign-up for Enzymotec Ltd. Initiates Clinical Study of Vayarin(R) in Adult ADHD investment picks
2014/11/19
EPIX Presents Road To The NHL Winter Classic™ and EPIX Presents Road To The NHL Stadium Series™ , a two-part original series from premium TV network EPIX and the National Hockey League, will bring U.S. viewers onto the ice and behind-the-scenes with the Chicago Blackhawks and Washington Capitals as they prepare to compete in the 2015 Bridgestone NHL Winter Classic®, and the Los Angeles Kings and San Jose Sharks on their road to the 2015 Coors Light NHL Stadium Series™. EPIX Presents Road To The NHL Winter Classic will make its U.S. Television Premiere on EPIX December 16 at 10pm ET/PT, 9CT with four weekly episodes following the Blackhawks and the Capitals through regular season games as they get ready to face off in the 2015 Bridgestone NHL Winter Classic® outdoor game at Nationals Park in Washington, D.C. on New Year’s Day, January 1.
Sign-up for EPIX Teams with National Hockey League for Two-Part, Eight-Episode Series, EPIX Presents Road To The NHL Winter Classic & EPIX Presents Road To The NHL Stadium Series investment picks
Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today the presentation of results from the company’s Phase 1 trial of EPZ-5676, a potent and selective inhibitor of the DOT1L histone methyltransferase (HMT). Epizyme, along with its partner Celgene, is developing EPZ-5676 for the treatment of acute leukemia with alterations in the MLL gene (MLL-r) or partial tandem duplications within MLL (MLL-PTD). The trial found that EPZ-5676 was generally safe and well tolerated across all dose cohorts and showed clinical and biological activity.
Sign-up for Epizyme DOT1L Inhibitor EPZ-5676 Shows Clinical and Biological Activity in Adult Patients with Acute Leukemias in Phase 1 Trial investment picks
EPR Properties (NYSE: EPR) (“EPR”) is pleased to announce that Empire Resorts, Inc.’s (“Empire”) wholly owned subsidiary, Montreign Operating Company, LLC (“Montreign”), its partner for the Gaming venue within EPR’s planned Adelaar four-season destination resort, has been selected in a unanimous vote by the New York State Gaming Facility Location Board (the “Board”) to apply to the New York State Gaming Commission (the “Gaming Commission”) for a Gaming Facility License.
Sign-up for EPR Properties’ Catskills Land Development Partner Selected by the New York State Gaming Facility Location Board investment picks
EQT Corporation (NYSE: EQT) today announced the Company’s 2015 capital expenditure (CAPEX) forecast of $2.5 billion, excluding business development and land acquisitions.
Sign-up for EQT Announces 2015 Operational Forecast investment picks
EQT Midstream Partners, LP (NYSE: EQM), an EQT Corporation (NYSE: EQT) company, today announced its 2015 financial and capital expenditure (CAPEX) forecast.
Sign-up for EQT Midstream Partners Announces 2015 Financial and CAPEX Forecast investment picks
2014/12/3
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0982169001&sourceType=1 http://www.ccnmatthews.com/logos/20110929-eq2.jpg TORONTO, ONTARIO --
Sign-up for Equifax Canada Reports Consumer Debt Grows to Over $1.5 Trillion investment picks
http://media.marketwire.com/attachments/201408/269546_52309_ERA_group_logo_RGB.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1153919&ProfileId=051205&sourceType=1 HOUSTON, TX --
Sign-up for Era Group Inc. Announces Q3 2014 Earnings Release Call investment picks
Eros International Plc (NYSE:EROS) (“Eros”), a leading global company in the Indian film entertainment industry, announced today its collaboration with Salman Khan Films for the global distribution rights to Bajrangi Bhaijaan and Hero .
Sign-up for Eros International Partners with Salman Khan Films for Global Rights to Bajrangi Bhaijaan & Hero investment picks
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that the European Medicines Agency (EMA) has validated and initiated its review of the company’s marketing authorization application (MAA) for Natpar ® (parathyroid hormone (rDNA)) for the treatment of Hypoparathyroidism, a rare endocrine disorder characterized by insufficient levels of parathyroid hormone (PTH). If approved, Natpar would be the first and only PTH replacement therapy in Europe for patients with Hypoparathyroidism.
Sign-up for European Medicines Agency Validates Marketing Authorization Application for Natpar® (parathyroid hormone (rDNA)) in Hypoparathyroidism investment picks
EverBank Financial Corp (NYSE: EVER) announced today that it will release its financial results for the fourth quarter ended December 31, 2014, prior to the market open on Wednesday, January 28, 2015, to be followed by a conference call at 8:30 a.m. ET the same day.
Sign-up for EverBank Financial Corp Announces Fourth Quarter 2014 Earnings and Conference Call Date investment picks
2015/1/8
Virtusa Corporation (NASDAQ GS: VRTU), a global business consulting and IT outsourcing company that combines innovation, technology leadership and industry solutions to transform the customer experience, today announced it has recently been named an Emerging Player in large capital markets application outsourcing relationships by Everest Group, an advisory and research firm on global services.
Sign-up for Everest Group Names Virtusa Emerging Player in PEAK Matrix™ for Large Capital Markets Application Outsourcing Relationships investment picks
EVERTEC, Inc. (NYSE: EVTC) (“EVERTEC” or the “Company”) today announced the appointment of Morgan "Mac" Schuessler as President and Chief Executive Officer, and Member of the Board of Directors, effective January 1, 2015.
Sign-up for EVERTEC Announces New CEO investment picks
Acquires DoctorDirectory, further strengthening ROI-based marketing solutions for the professional market NEW YORK , Nov.
Sign-up for Everyday Health Reports Third Quarter 2014 Financial Results investment picks
http://media.marketwire.com/attachments/201411/82013_292277_EVINELive_LOGO_RGB.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1160853&ProfileId=051205&sourceType=1 MINNEAPOLIS, MN --
Sign-up for EVINE Live Inc. CEO Mark Bozek Shares Company Vision on Bloomberg TV investment picks
http://media.marketwire.com/attachments/201501/TN-298864_Gerten.jpg Wade Gerten, Vice President of Digital at EVINE Live http://media.marketwire.com/attachments/201411/82013_292277_EVINELive_LOGO_RGB.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1167336&ProfileId=051205&sourceType=1 MINNEAPOLIS, MN --
Sign-up for EVINE Live Inc. Names Wade Gerten Vice President of Digital investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Popular Articles From: Energy stocks are top decliners in S&P 500 to EVINE Live Inc. Names Wade Gerten Vice President of Digital
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent